120 related articles for article (PubMed ID: 38545939)
1. Glutathione-Responsive and Hydrogen Sulfide Self-Generating Nanocages Based on Self-Weaving Technology To Optimize Cancer Immunotherapy.
Gou S; Geng W; Zou Y; Chen F; He T; Duan Q; Qin Z; Li L; Xia J; Yu Y; Feng Q; Cai K
ACS Nano; 2024 Apr; 18(14):9871-9885. PubMed ID: 38545939
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
3. Cu
Xu H; Su Z; Zhang H; Zhang Y; Bao Y; Zhang H; Wu X; Yan R; Wang Z; Jin Y
Int J Pharm; 2023 Jun; 640():123002. PubMed ID: 37254284
[TBL] [Abstract][Full Text] [Related]
4. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery.
Kyu Shim M; Yang S; Sun IC; Kim K
Adv Drug Deliv Rev; 2022 Apr; 183():114177. PubMed ID: 35245568
[TBL] [Abstract][Full Text] [Related]
5. Janus Silica Nanoparticle-Based Tumor Microenvironment Modulator for Restoring Tumor Sensitivity to Programmed Cell Death Ligand 1 Immune Checkpoint Blockade Therapy.
Lin X; Li F; Guan J; Wang X; Yao C; Zeng Y; Liu X
ACS Nano; 2023 Aug; 17(15):14494-14507. PubMed ID: 37485850
[TBL] [Abstract][Full Text] [Related]
6. GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy.
Ma T; Li W; Ye J; Huang C; Li Y; Qiu H; Yin S
Nanoscale; 2023 Nov; 15(42):16947-16958. PubMed ID: 37779508
[TBL] [Abstract][Full Text] [Related]
7. Cascade-Responsive Hierarchical Nanosystems for Multisite Specific Drug Exposure and Boosted Chemoimmunotherapy.
Zhang J; Zhang Y; Zhao B; Lv M; Chen E; Zhao C; Jiang L; Qian H; Huang D; Zhong Y; Chen W
ACS Appl Mater Interfaces; 2021 Dec; 13(49):58319-58328. PubMed ID: 34855343
[TBL] [Abstract][Full Text] [Related]
8. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
9. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
[TBL] [Abstract][Full Text] [Related]
10. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
11. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
12. A tumor microenvironment-activatable nanoplatform with phycocyanin-assisted in-situ nanoagent generation for synergistic treatment of colorectal cancer.
Sun X; Liang X; Wang Y; Ma P; Xiong W; Qian S; Cui Y; Zhang H; Chen X; Tian F; Shi Y; Zheng F; Li L
Biomaterials; 2023 Oct; 301():122263. PubMed ID: 37549506
[TBL] [Abstract][Full Text] [Related]
13. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
Zhang R; Wan Y; Lv H; Li F; Lee CS
J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052
[TBL] [Abstract][Full Text] [Related]
14. A tumor microenvironment responsive biodegradable CaCO
Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
[TBL] [Abstract][Full Text] [Related]
15. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
[TBL] [Abstract][Full Text] [Related]
16. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a
Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z
Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476
[No Abstract] [Full Text] [Related]
17. Smart Nanoplatform for Visualizing Hydrogen Sulfide and Amplifying Oxidative Stress to Tumor Apoptosis.
Chen HY; Xu HB; Lv J; Chang S; Wu MS; Chen ZC; Zhu SC; He Y; Qian RC; Li DW
ACS Sens; 2023 Sep; 8(9):3555-3562. PubMed ID: 37607401
[TBL] [Abstract][Full Text] [Related]
18. Cytokine induced killer cells-assisted delivery of chlorin e6 mediated self-assembled gold nanoclusters to tumors for imaging and immuno-photodynamic therapy.
Xia F; Hou W; Liu Y; Wang W; Han Y; Yang M; Zhi X; Li C; Qi D; Li T; Martinez de la Fuente J; Zhang C; Song J; Cui D
Biomaterials; 2018 Jul; 170():1-11. PubMed ID: 29635107
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
20. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
